Assessing the Clinical Utility of Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer

  • J Clin Oncol. 2023 Feb 20;41(6):1323. doi: 10.1200/JCO.22.01759.
Zachary R McCaw  1 ,  Ethan B Ludmir  1 ,  Lee-Jen Wei  1
Affiliations
  • 1. Zachary R. McCaw, PhD, Insitro, South San Francisco, CA; Ethan B. Ludmir, MD, The University of Texas MD Anderson Cancer Center, Houston, TX; and Lee-Jen Wei, PhD, Harvard T.H. Chan School of Public Health, Boston, MA.
PMID: 36331242 DOI: 10.1200/JCO.22.01759
Products